Company intelligence / Profile preview
eGenesis
Cambridge, Massachusetts, United Statesegenesisbio.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Phase 1
01
Overview
eGenesis achieved the world’s first successful porcine kidney transplant into a living patient in March 2024. The lead candidate kidney carries three classes of genetic edits to address immunological rejection and viral safety. Durable preclinical success has been demonstrated across multiple organ types. The company’s approach offers a potential solution to the global shortage of transplantable organs by providing genetically engineered animal organs compatible with humans.
- Therapeutic areas
- GastroenterologyCardiovascularNephrology
- Modalities
- Multiplex gene editing (CRISPR-based)genome engineeringxenotransplantation of organs and cells
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Massachusetts General Hospital (for clinical trial/execution)Lux Capital
Beyond the preview
Go deeper on eGenesis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on eGenesis.